COVID-19 vaccination highly effective in individuals with immune-related inflammatory diseases

Montreal, May 3, 2022 – New findings, published in The Lancet Rheumatology, suggest that people with immune-mediated inflammatory diseases (IMIDs) respond well to vaccination and that the COVID-19 vaccines in Canada are highly effective in protecting them against hospitalization from COVID-19.

Related Keywords

Montreal ,Quebec ,Canada ,Netherlands ,Toronto ,Ontario ,Sunnybrook ,Alberta ,Holland ,Canadians ,Catherine Hankins ,Biontech Comirnaty ,Jessica Widdifield ,Fabienne Landry ,Sasha Bernatsky ,Samantha Sexton ,Moderna Spikevax ,Rebecca Burns ,Immunity Task Force ,Research Institute Of Mcgill University Health Centre ,Department Of Medicine At Mcgill University ,Pfizer ,University Of Toronto ,Program At Sunnybrook Health Sciences Centre ,Immunity Task ,Leadership Group ,Sunnybrook Health Sciences Centre ,Mcgill University Health Centre ,Immunity In Global Health Program ,Sunnybrook Health Science Centre ,Faculty Of Medicine Mcgill University ,Infectious Diseases ,Global Health Program ,Research Institute ,Lancet Rheumatology ,Task Force ,Holland Bone ,Joint Program ,Sunnybrook Health Sciences ,Clinical Epidemiology ,Mcgill University ,Mcgill University Health ,Health Sciences Centre ,Montreal General Hospital ,